MHApp - Malignant Hyperthermia is an overall app developed by Girard Development GmbH.
How many times has MHApp - Malignant Hyperthermia been downloaded?
What is the rating of MHApp - Malignant Hyperthermia?
MHApp - Malignant Hyperthermia is rated 4.11 out of 5 stars, based on 9 ratings.
Is MHApp - Malignant Hyperthermia free?
MHApp - Malignant Hyperthermia is free to download. The APK download size is 4.38 MB. The latest version available is 2.4. The last update was on October 21, 2022.
What are the requirements for MHApp - Malignant Hyperthermia?
The app has a content rating of Medium Maturity. The app has been available on Google Play October 2010.
Description
Finally it’s back! The much appreciated MHApp is finally back in the AppStore. Rewritten from ground up in Swift. A modern user interface.
And the best is: it is free of charge!
Please note: MHApp is not a substitute for medical advice. MHApp is intended for educational purposes only. The purpose of this app is to use it to train and teach yourself in management of malignant hyperthermia. It might serve as a valuable tool in simulated MH scenarios.
Do you know what to do in case of a malignant hyperthermia crisis? Are you sure somebody will take a detailed protocol during your actions?
MHApp does both for you: MHApp is like an interactive MH-emercency poster. Simulating an MH crisis and teaching the acute management will certainly be of great value in case of a real crisis. MHApp will guide you through a simulated malignant hyperthermia (MH) crisis. The App includes treatment of acidosis, hyperkalemia and dosing of dantrolene or ryanodex Every action and injected dantrolene doses are recorded in a log file, which can be exported.
The clinical grading score (CGS) estimates the probability of an MH episode. The result can be exported as PDF.
A section with information about MH, anesthesia for the known MH patients, preparation of anesthesia workstations, MH-mutations and more.
This app was developed by international experts in Malignant Hyperthermia: Dr. Henry Rosenberg (President of MHAUS) Prof. Thierry Girard (director of the Swiss MH unit)
MHApp is endorsed by the North American MH Group (www.mhaus.org), as well as by the European MH Group (www.emhg.org).
Programmed by Thierry Girard, Girard Development GmbH
DISCLAIMER: The application MHApp is not a substitute for medical advice. MHApp is intended for educational purposes only. While the data may be updated periodically, users should independently check medical literature and package inserts or other sources for the latest information. Any and all liability arising directly or indirectly from the use of this application is hereby disclaimed. The information herein is provided "as is" and without any warranty expressed or implied. All direct, indirect, special, incidental, consequential or punitive damages arising from any use of this application or data contained herein is disclaimed and excluded.
Each subscription will automatically renew 3 days before the expiration date for
the same time period. Subscriptions can be cancelled at any time before the renewal.